Wnt5a, TLR2 and TLR4 are elevated in advanced human atherosclerotic lesions

The nuclear hormone receptor PPARγ counteracts vascular calcification by inhibiting Wnt5a signalling in vascular smooth muscle cells

(2012) Estelle Woldt et al.   Nature Communications

Heart Disease and Stroke Statistics—2012 Update

(2011) et al.   CIRCULATION

Adipose tissue macrophages inhibit adipogenesis of mesenchymal precursor cells via wnt-5a in humans

(2011) R Bilkovski et al.   INTERNATIONAL JOURNAL OF OBESITY

Wnt signaling in macrophages: Augmenting and inhibiting mycobacteria-induced inflammatory responses

(2010) Kolja Schaale et al.   EUROPEAN JOURNAL OF CELL BIOLOGY

Wnt5a Induces Endothelial Inflammation via  -Catenin-Independent Signaling

(2010) J. Kim et al.   JOURNAL OF IMMUNOLOGY

Toll like receptor 4 in atherosclerosis and plaque destabilization

(2009) Wijnand K. den Dekker et al.   ATHEROSCLEROSIS

Toll-Like Receptor-2 Mediates Inflammation and Matrix Degradation in Human Atherosclerosis

(2009) Claudia Monaco et al.   CIRCULATION

Phenylmethimazole Decreases Toll-Like Receptor 3 and Noncanonical Wnt5a Expression in Pancreatic Cancer and Melanoma Together with Tumor Cell Growth and Migration

(2009) A. L. Schwartz et al.   CLINICAL CANCER RESEARCH

The Wnt pathway: A macrophage effector molecule that triggers inflammation

(2009) Claudia P. Pereira et al.   Current Atherosclerosis Reports

The Roles of Toll-Like Receptors in Atherosclerosis

(2009) Clett Erridge   Journal of Innate Immunity

Wnt5a is expressed in murine and human atherosclerotic lesions

(2008) Mark A. Christman et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Wnt Pathway

(2008) Sarah Jane George   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Wnt5A/CaMKII Signaling Contributes to the Inflammatory Response of Macrophages and Is a Target for the Antiinflammatory Action of Activated Protein C and Interleukin-10

(2008) Claudia Pereira et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY